SAN DIEGO, Calif., July 26, 2022 (GLOBE NEWSWIRE) — Trans NewMediaWire – Medical marijuana, Inc. (Off-the-shelf: MJNA) (“the Company”), the first publicly traded cannabis company in the United States that launched the world’s first cannabis-derived products, brands, and supply chain, today announced that its CEO Blake Schroeder has published an article in Nasdaq News to provide the industry with insight into the future of legalization. Federal cannabis in the United States
In his article titled, “How CBD Market Utilization Can Set a Strong Stage for American Hemp”In , Blake explains how the non-psychoactive CBD cannabis market presents a unique opportunity to build a customer base and lay the groundwork for sales of psychoactive THC products once they are federally legal. He explains how the THC market, which is currently only legal on a state-by-state basis, can learn from the regulatory, testing, banking, legal, and other business-related challenges that the CBD market overcame prior to the passage of the 2018 Agriculture Act. It highlights how this can help companies aiming to be in the THC space create a strong foundation for a federally legal market and provide consumers with safe products.
Blake also highlights the importance of international product pipelines as they present unique opportunities and challenges to provide free access to cannabis products to people around the world and access new and untapped markets that may ease cannabis sales restrictions in the future.
“I am very proud of the hard work our company has done to create the legitimate and legal market for non-psychoactive cannabis that we have today, and I’m excited to see that replicated in the THC market once our federal legislation changes,” said Medical Marijuana, CEO Blake Schroeder. “We think we’re well positioned in this area when it becomes federal law. We have a global infrastructure that we can take advantage of as laws around the world change for the better.”
To learn more about the company, please visit https://www.medicalmarijuanainc.com/.
About Medical Marijuana, Inc.
We are Firsts®. Medical marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabis space: a global group of hemp-based nutritional brands led by Kanawee® And HempMeds®; leader in sourcing high quality, legal, non-psychoactive cannabis products derived from industrial hemp; and the cannabis-based clinical research and plant-based drug development segment led by pharmaceutical investment firms and their partners incl AXIM® Biotechnologies, Inc. And Neurobatics. Medical Marijuana, Inc. As the best CBD product by CNBC. Medical Marijuana, Inc. Also the first company to obtain historical import authorizations for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a leader in the development of international markets. The company’s main product Real scientific hemp oil It has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc. is headquartered in In San Diego, California, additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. Watch the Medical Marijuana, Inc. video. , click here.
Forward-looking Disclaimer
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934, and is subject to the safe harbor laws established by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and are subject to risks and uncertainties. These forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to differ. substantially from the data presented here.
Disclosure to the Food and Drug Administration (FDA)
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, cure, or prevent any disease.
Legal disclosure
Medical Marijuana, Inc. does not sell or distribute any products that violate the US Controlled Substances Act.
communication:
PR contact:
Catherine Brown
account manager
CMW Media
pp. 858-221-8001
[email protected]
www.cmwmedia.com
Investor Relations Contact:
P. (858) 283-4016
[email protected]
